NASDAQ: CNTX - Context Therapeutics Inc.

六个月盈利: -66.58%
股息率: 0.00%
部门: Healthcare

促销时间表 Context Therapeutics Inc.


关于公司 Context Therapeutics Inc.

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors in the United States. It develops CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.


IPO date 2021-10-20
ISIN US21077P1084
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.contexttherapeutics.com
Цена ао 0.7909
每日价格变化: -11.05% (0.7365)
每周价格变化: -15.12% (0.7718)
每月价格变化: -22.93% (0.85)
3个月内价格变化: -40.45% (1.1)
六个月内的价格变化: -66.58% (1.96)
每年价格变化: -52.53% (1.38)
3年内价格变化: -71.52% (2.3)
年初以来价格变化: -38.2% (1.06)

低估

姓名 意义 年级
P/S 0 0
P/BV 1.55 8
P/E 0 0
EV/EBITDA -0.1593 0
全部的: 3.5

效率

姓名 意义 年级
ROA, % -149.19 0
ROE, % -201.87 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0022 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 364.08 10
盈利能力 EPS, % 104.74 10
全部的: 8



导师 职称 支付 出生年份
Mr. Martin A. Lehr Co-Founder, President, CEO & Director 674.08k 1984 (41 年)
Ms. Jennifer Minai-Azary CFO & Treasurer 504.14k 1978 (47 年)
Mr. Alex C. Levit Esq. Chief Legal Officer & Corporate Secretary 483.83k 1979 (46 年)
Mr. Christopher Beck M.B.A. Senior Vice President of Operations N/A
Dr. Claudio Dansky Ullmann M.D. Chief Medical Officer

地址: United States, Philadelphia. PA, 2001 Market Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.contexttherapeutics.com